Breast cancer patients should pay more attention to the whole process management of patients, so the improvement of HR+/HER2- advanced breast cancer diagnosis and treatment quality must be based on multidisciplinary cooperation, regular multidisciplinary cooperation, a more comprehensive understanding of patient characteristics, and enabling patients to receive more standard and personalized treatment. The gene discussed is ERBB2; the disease is breast cancer.